Original Disciple III · Established endogenous mediator

Bradykinin

The Messenger of Pain

Instituto Biológico · São Paulo, Brazil · 1948

Bradykinin is a short-lived signal involved in inflammation, pain, blood-vessel widening, and swelling. Its effects help explain how the body responds to injury, but the same signaling can become harmful when excessive. This profile concerns a biological messenger rather than a wellness treatment.

Evidence ladder: Controlled human evidenceEstablished biology · indication-specific medicineEducational record

ClassificationOriginal Disciples

Evidence summaryEstablished biology · indication-specific medicine

OriginInstituto Biológico · São Paulo, Brazil · 1948

Scientific record

What the evidence says

Roles or demonstrated benefits

Contributes to normal vascular regulation and inflammatory signaling.
Pain signaling helps alert the body to injury.
Its pathway led to major insights in cardiovascular pharmacology.

Risks, side effects, and limits

Excess signaling can contribute to pain, swelling, low blood pressure, and angioedema.
It helps explain some ACE-inhibitor cough and angioedema.
It is not administered as a wellness peptide.

Doctide’s verdict

A messenger can be indispensable without being comfortable—or something to add more of. Bradykinin earns its place by explaining pain and vascular responses, not by offering a general recovery promise.

Documented history

Where the story actually begins

Rocha e Silva, Beraldo, and Rosenfeld’s 1949 original report described a blood-pressure-lowering, smooth-muscle-stimulating factor released from plasma proteins by snake venom and trypsin. The report documents the experimental work behind bradykinin’s discovery, rather than a trial of a consumer therapy.

Instituto Biológico · São Paulo, Brazil · 1948

Book of the Canon · Comic scripture

The laboratory legend

Bradykinin touched the only unlabeled hot plate. His shout shattered two beakers and established the first safety rule: pain is information, but labeling things is cheaper.

This bold passage is invented comedy, not scientific or historical fact.

Questions readers ask

Plain-language answers

What does bradykinin do?

Bradykinin is a signaling peptide involved in pain and inflammation. It can widen blood vessels and make them more permeable, helping the body signal injury while also contributing to swelling and lower blood pressure.

Is bradykinin beneficial or harmful?

Both descriptions can be true. Normal bradykinin signaling has physiological roles, while excessive or poorly controlled signaling can contribute to pain, swelling, and angioedema.

Why is bradykinin linked to ACE-inhibitor cough and angioedema?

ACE helps break down bradykinin. ACE-inhibitor medicines can therefore allow bradykinin to accumulate in some people, which is one proposed contributor to cough and the rare but serious swelling reaction called angioedema.

Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 22, 2026

Evidence ledger

Sources

Fiction disclosure: The bold laboratory legend above is invented. The historical and scientific sections are intended as sourced summaries; no invented connective events were added to the documented history.

Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.